BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3115020)

  • 1. An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months.
    Fraser HM; Sandow J; Seidel H; von Rechenberg W
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):521-7. PubMed ID: 3115020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion.
    Fraser HM; Haining R; Cowen GM; Sandow J; Smith KB; Smith SK
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):97-104. PubMed ID: 1559303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM; Lunn SF
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of a GnRH agonist from a polyhydroxybutyric acid implant: reversible suppression of the menstrual cycle in the macaque.
    Fraser HM; Sandow J; Seidel HR; Lunn SF
    Acta Endocrinol (Copenh); 1989 Dec; 121(6):841-8. PubMed ID: 2514544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin secretion after treatment with an LHRH agonist and subsequent ovarian hyperstimulation induced by FSH in the macaque (Macaca arctoides).
    Fraser HM; Smith KB; Reddi K; Lunn SF
    J Reprod Fertil; 1990 Jul; 89(2):441-6. PubMed ID: 2119427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the gonad on the degree of suppression induced by an LHRH agonist implant in the marmoset monkey.
    Lunn SF; Cowen GM; Morris KD; Fraser HM
    J Endocrinol; 1992 Feb; 132(2):217-24. PubMed ID: 1541921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
    Fraser HM; Sandow J
    J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
    Fraser HM; Abbott M; Laird NC; McNeilly AS; Nestor JJ; Vickery BH
    J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist.
    Gong JG; Campbell BK; Bramley TA; Gutierrez CG; Peters AR; Webb R
    Biol Reprod; 1996 Jul; 55(1):68-74. PubMed ID: 8793060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periovulatory endocrine events in the stumptailed monkey (macaca arctoides).
    Wilks JW; Marciniak RD; Hildebrand DL; Hodgen GD
    Endocrinology; 1980 Jul; 107(1):237-44. PubMed ID: 6769663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gonadotrophin-releasing hormone agonist-induced suppression of LH and FSH on follicle growth and corpus luteum function in the ewe.
    McNeilly AS; Fraser HM
    J Endocrinol; 1987 Nov; 115(2):273-82. PubMed ID: 3125300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.